-
Civica to Build an Essential Medicines Manufacturing Facility in Virginia
contractpharma
January 26, 2021
Civica Rx has unveiled plans to build a 120,000 square-foot sterile injectable manufacturing facility in Petersburg, VA, potentially creating more than 180 jobs. The new plant represents a $124.5 million investment.
-
Northway Biotech Opens New Biopharmaceutical Manufacturing Facility in Greater Boston Area
prnasia
January 21, 2021
Northway Biotech, a biopharmaceutical contract development and manufacturing organization (CDMO), established in 2004, with an EMA and FDA-compliant, state-of-the-art, cGMP manufacturing site in Europe, announced at the virtual grand opening ceremony ...
-
Fujifilm to Invest $40M in New Facility
contractpharma
January 06, 2021
Fujifilm Corporation has announced an investment of approximately $40 million in Fujifilm Diosynth Biotechnologies, a contract development and manufacturing organization (CDMO) for biologics, viral vaccines and viral vectors, to establish a new ...
-
Oncorus to Build GMP Viral Immunotherapy Mfg. Facility
contractpharma
January 05, 2021
Oncorus, Inc., a clinical stage biopharmaceutical company developing next-gen viral immunotherapies for cancer, has signed a 15-year lease to build a state-of-the-art, 88,000 sq.-ft. GMP viral immunotherapy clinical manufacturing facility in Andover ...
-
Wallace Pharma sets up R&D Centre in Goa
expresspharma
January 04, 2021
Mumbai-based Wallace Pharma has set up a research and development (R&D) centre ‘Wallace Innovation Centre’ in Ponda, Goa.
-
Lonza Expands Conjugation Facility in Visp
contractpharma
December 22, 2020
Two additional manufacturing suites will provide development and manufacturing capacity for preclinical to commercial supply.
-
Thermo Fisher Expands Plasmid DNA Mfg. Capabilities
contractpharma
December 18, 2020
New 67,000-square-foot Carlsbad, CA cGMP site will accelerate commercialization of plasmid-based medicines and vaccines.
-
Aurinia and Lonza Expand Manufacturing Partnership
contractpharma
December 17, 2020
Aurinia Pharmaceuticals and Lonza have expanded their exclusive manufacturing relationship. The parties entered into a collaborative agreement to build a dedicated manufacturing capacity within Lonza’s existing small molecule API facility in Visp ...
-
Catalent Appoints Minakuchi Facility GM
contractpharma
December 11, 2020
Catalent has appointed Nakaya “Nick” Matsumaru as general manager of its new clinical packaging facility in Minakuchi, located in the Shiga prefecture of Japan.
-
Piramal Pharma Solutions invests ~$32 mn in its Riverview Michigan facility
expresspharma
December 10, 2020
Piramal Pharma’s Pharma Solutions business announced plans to expand its facility in Michigan with additional capacity and new capabilities for the development and manufacturing of active pharma ingredients (APIs).